Loading
Every connected record, the notes, the JSON, Markdown and RDF twins, and where the record came from and when it was checked.
Direct links plus the targets, companies, and technologies of this cancer's products.
Shares Tremelimumab, Ipilimumab, Durvalumab, Nivolumab and the tag subtype-page.
Shares Andrew X. Zhu, Radioembolisation (TARE / SIRT, yttrium-90), SBRT / SABR (stereotactic radiotherapy), Durvalumab and the tag subtype-page.
Shares Cabozantinib, Lenvatinib, Ipilimumab, Nivolumab and the tag subtype-page.
Shares Ramucirumab, Durvalumab, Nivolumab and the tag subtype-page.
Shares Regorafenib, Ipilimumab, Nivolumab and the tag subtype-page.
Shares Ipilimumab, Bevacizumab, Nivolumab and the tag subtype-page.
Shares Sorafenib, Lenvatinib and the tag subtype-page.
Shares Cabozantinib, Lenvatinib and the tag subtype-page.
The same record for scripts and assistants; checked 2026-09-17. Data CC BY-NC 4.0, attribute “Data from OnCo (onco.cc)”.